BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL, Wang HY, Xie D, Luo JH. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol. 2013;14:1295-1306. [PMID: 24239208 DOI: 10.1016/s1470-2045(13)70491-1] [Cited by in Crossref: 328] [Cited by in F6Publishing: 237] [Article Influence: 36.4] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Bu J, Liu X, Wang W, Mai W, Lv B, Zou J, Mo X, Li X, Wang J, Niu B, Fan Y, Hou B. miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer. Oncotarget 2017;8:63935-48. [PMID: 28969042 DOI: 10.18632/oncotarget.19212] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
2 Sabarimurugan S, Madhav MR, Kumarasamy C, Gupta A, Baxi S, Krishnan S, Jayaraj R. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Mol Diagn Ther 2020;24:15-30. [PMID: 32020560 DOI: 10.1007/s40291-019-00440-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Vrijens K, Bollati V, Nawrot TS. MicroRNAs as potential signatures of environmental exposure or effect: a systematic review. Environ Health Perspect 2015;123:399-411. [PMID: 25616258 DOI: 10.1289/ehp.1408459] [Cited by in Crossref: 181] [Cited by in F6Publishing: 171] [Article Influence: 25.9] [Reference Citation Analysis]
4 Zhang L, Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zhao XM. A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma. Oncotarget 2016;7:3587-98. [PMID: 26657296 DOI: 10.18632/oncotarget.6534] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
5 Gutiérrez ML, Corchete LA, Sarasquete ME, Del Mar Abad M, Bengoechea O, Fermiñán E, Anduaga MF, Del Carmen S, Iglesias M, Esteban C, Angoso M, Alcazar JA, García J, Orfao A, Muñoz-Bellvís L, Sayagués JM. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors. Oncotarget 2017;8:107685-700. [PMID: 29296198 DOI: 10.18632/oncotarget.22591] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
6 Ye L, Zhang T, Kang Z, Guo G, Sun Y, Lin K, Huang Q, Shi X, Ni Z, Ding N, Zhao KN, Chang W, Wang J, Lin F, Xue X. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer. Front Immunol 2019;10:2368. [PMID: 31681276 DOI: 10.3389/fimmu.2019.02368] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
7 To KK, Tong CW, Wu M, Cho WC. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. World J Gastroenterol 2018; 24(27): 2949-2973 [PMID: 30038463 DOI: 10.3748/wjg.v24.i27.2949] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 67] [Article Influence: 16.8] [Reference Citation Analysis]
8 Dong Y, Yu J, Ng SS. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Manag Res 2014;6:405-22. [PMID: 25342918 DOI: 10.2147/CMAR.S35164] [Cited by in Crossref: 11] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
9 Hung CL, Yen CS, Tsai HW, Su YC, Yen CJ. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease. BMC Cancer. 2015;15:665. [PMID: 26453548 DOI: 10.1186/s12885-015-1671-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
10 Ullmann P, Qureshi-Baig K, Rodriguez F, Ginolhac A, Nonnenmacher Y, Ternes D, Weiler J, Gäbler K, Bahlawane C, Hiller K, Haan S, Letellier E. Hypoxia-responsive miR-210 promotes self-renewal capacity of colon tumor-initiating cells by repressing ISCU and by inducing lactate production. Oncotarget 2016;7:65454-70. [PMID: 27589845 DOI: 10.18632/oncotarget.11772] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
11 Jin Y, Wang L, Lou H, Song C, He X, Ding M. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer. Comb Chem High Throughput Screen 2021;24:98-108. [PMID: 32593277 DOI: 10.2174/1386207323666200627212820] [Reference Citation Analysis]
12 Luo Q, Song H, Deng X, Li J, Jian W, Zhao J, Zheng X, Basnet S, Ge H, Daniel T, Xu B, Fang L. A Triple-Regulated Oncolytic Adenovirus Carrying MicroRNA-143 Exhibits Potent Antitumor Efficacy in Colorectal Cancer. Mol Ther Oncolytics 2020;16:219-29. [PMID: 32123722 DOI: 10.1016/j.omto.2020.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Yang Q, Qin J, Sun G, Qiu C, Jiang D, Ye H, Wang X, Dai L, Zhu J, Wang P, Zhang J. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays. Clin Transl Gastroenterol 2020;12:e00284. [PMID: 33346593 DOI: 10.14309/ctg.0000000000000284] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Zhou X, Wang X, Huang Z, Xu L, Zhu W, Liu P. An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer. J Exp Clin Cancer Res 2014;33:94. [PMID: 25373603 DOI: 10.1186/s13046-014-0094-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
15 Lai J, Wang H, Pan Z, Su F. A novel six-microRNA-based model to improve prognosis prediction of breast cancer. Aging (Albany NY) 2019;11:649-62. [PMID: 30696800 DOI: 10.18632/aging.101767] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
16 Li T, Xiong Q, Zou Z, Lei X, Jiang Q, Liu D. Prognostic significance of cystatin SN associated nomograms in patients with colorectal cancer. Oncotarget 2017;8:115153-63. [PMID: 29383149 DOI: 10.18632/oncotarget.23041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
17 Du F, Yuan P, Zhao ZT, Yang Z, Wang T, Zhao JD, Luo Y, Ma F, Wang JY, Fan Y, Cai RG, Zhang P, Li Q, Song YM, Xu BH. A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment. Sci Rep 2016;6:33825. [PMID: 27650797 DOI: 10.1038/srep33825] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
18 Ozawa T, Kandimalla R, Gao F, Nozawa H, Hata K, Nagata H, Okada S, Izumi D, Baba H, Fleshman J, Wang X, Watanabe T, Goel A. A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes. Gastroenterology 2018;154:844-848.e7. [PMID: 29199088 DOI: 10.1053/j.gastro.2017.11.275] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
19 Liu K, Wang L, Sun E. Prognostic value of miR-221 in human malignancy: evidence from 3041 subjects. BMC Cancer 2019;19:867. [PMID: 31470827 DOI: 10.1186/s12885-019-6079-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Altaf-Ul-Amin M, Karim MB, Hu P, Ono N, Kanaya S. Discovery of inflammatory bowel disease-associated miRNAs using a novel bipartite clustering approach. BMC Med Genomics 2020;13:10. [PMID: 32093721 DOI: 10.1186/s12920-020-0660-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Xiong Y, Wang R, Peng L, You W, Wei J, Zhang S, Wu X, Guo J, Xu J, Lv Z. An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer. Oncotarget. 2017;8:85463-85478. [PMID: 29156733 DOI: 10.18632/oncotarget.20013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
22 Nsengimana J, Laye J, Filia A, Walker C, Jewell R, Van den Oord JJ, Wolter P, Patel P, Sucker A, Schadendorf D, Jönsson GB, Bishop DT, Newton-Bishop J. Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort. Oncotarget 2015;6:11683-93. [PMID: 25871393 DOI: 10.18632/oncotarget.3549] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
23 Ren J, Xu L, Zhou S, Ouyang J, You W, Sheng N, Yan L, Peng D, Xie L, Wang Z. Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study. Front Oncol 2021;11:776997. [PMID: 34926285 DOI: 10.3389/fonc.2021.776997] [Reference Citation Analysis]
24 Zhou H, Tang K, Xiao H, Zeng J, Guan W, Guo X, Xu H, Ye Z. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer. J Exp Clin Cancer Res 2015;34:53. [PMID: 25991007 DOI: 10.1186/s13046-015-0167-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
25 Nguyen HT, Kacimi SEO, Nguyen TL, Suman KH, Lemus-Martin R, Saleem H, Do DN. MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology (Basel) 2021;10:417. [PMID: 34066762 DOI: 10.3390/biology10050417] [Reference Citation Analysis]
26 Bobowicz M, Skrzypski M, Czapiewski P, Marczyk M, Maciejewska A, Jankowski M, Szulgo-Paczkowska A, Zegarski W, Pawłowski R, Polańska J, Biernat W, Jaśkiewicz J, Jassem J. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer. Clin Exp Metastasis 2016;33:765-73. [PMID: 27485175 DOI: 10.1007/s10585-016-9810-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
27 Neerincx M, Poel D, Sie DLS, van Grieken NCT, Shankaraiah RC, van der Wolf-de Lijster FSW, van Waesberghe JTM, Burggraaf JD, Eijk PP, Verhoef C, Ylstra B, Meijer GA, van de Wiel MA, Buffart TE, Verheul HMW. Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer. PLoS One 2018;13:e0201809. [PMID: 30075027 DOI: 10.1371/journal.pone.0201809] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
28 Deng GC, Lv Y, Yan H, Sun DC, Qu TT, Pan YT, Han QL, Dai GH. Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer. BMC Cancer 2021;21:1227. [PMID: 34781928 DOI: 10.1186/s12885-021-08943-w] [Reference Citation Analysis]
29 Lin YW, Kang WP, Huang BL, Qiu ZH, Wei LF, Zhang B, Ding TY, Luo Y, Liu CT, Chu LY, Guo HP, Xu YW, Peng YH. Nomogram based on clinical characteristics and serological inflammation markers to predict overall survival of oral tongue squamous cell carcinoma patient after surgery. BMC Oral Health 2021;21:667. [PMID: 34961504 DOI: 10.1186/s12903-021-02028-7] [Reference Citation Analysis]
30 Rui T, Zhang X, Feng S, Huang H, Zhan S, Xie H, Zhou L, Ling Q, Zheng S. The Similar Effects of miR-512-3p and miR-519a-2-5p on the Promotion of Hepatocellular Carcinoma: Different Tunes Sung With Equal Skill. Front Oncol 2020;10:1244. [PMID: 32850377 DOI: 10.3389/fonc.2020.01244] [Reference Citation Analysis]
31 Shi L, Tao C, Tang Y, Xia Y, Li X, Wang X. Hypoxia-induced hsa_circ_0000826 is linked to liver metastasis of colorectal cancer. J Clin Lab Anal 2020;34:e23405. [PMID: 32633429 DOI: 10.1002/jcla.23405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
32 Wang J, Yan F, Zhao Q, Zhan F, Wang R, Wang L, Zhang Y, Huang X. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer. Sci Rep. 2017;7:4150. [PMID: 28646161 DOI: 10.1038/s41598-017-04386-1] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 15.8] [Reference Citation Analysis]
33 Honda M, Oba K, Akiyoshi T, Maeda H, Kashiwabara K, Kanda M, Mayanagi S, Aoyama T, Hamada C, Sadahiro S, Fukunaga Y, Ueno M, Sakamoto J, Saji S, Yoshikawa T. Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials. Oncotarget 2017;8:99150-60. [PMID: 29228760 DOI: 10.18632/oncotarget.21845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
34 Barchitta M, Maugeri A, Li Destri G, Basile G, Agodi A. Epigenetic Biomarkers in Colorectal Cancer Patients Receiving Adjuvant or Neoadjuvant Therapy: A Systematic Review of Epidemiological Studies. Int J Mol Sci 2019;20:E3842. [PMID: 31390840 DOI: 10.3390/ijms20153842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
35 Pan Z, Bu Q, You H, Yang J, Liu Q, Lyu J. Determining the optimal cutoff point for lymph node density and its impact on overall survival in children with Wilms' tumor. Cancer Manag Res 2019;11:759-66. [PMID: 30697068 DOI: 10.2147/CMAR.S190138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Fu M, Chen D, Luo F, Wang G, Xu S, Wang Y, Sun C, Xu X, Li A, Zhuo S, Liu S, Yan J. Development and validation of a collagen signature-based nomogram for preoperatively predicting lymph node metastasis and prognosis in colorectal cancer. Ann Transl Med 2021;9:651. [PMID: 33987349 DOI: 10.21037/atm-20-7565] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Tian X, Zhu X, Meng W, Bai S, Shi M, Xiang S, Zhao C, Wang Y. A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer. Aging (Albany NY) 2020;12:18363-83. [PMID: 32855365 DOI: 10.18632/aging.103707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Ju HQ, Zhao Q, Wang F, Lan P, Wang Z, Zuo ZX, Wu QN, Fan XJ, Mo HY, Chen L, Li T, Ren C, Wan XB, Chen G, Li YH, Jia WH, Xu RH. A circRNA signature predicts postoperative recurrence in stage II/III colon cancer. EMBO Mol Med 2019;11:e10168. [PMID: 31475771 DOI: 10.15252/emmm.201810168] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 12.3] [Reference Citation Analysis]
39 Lin W, Zou H, Mo J, Jin C, Jiang H, Yu C, Jiang Z, Yang Y, He B, Wang K. Micro1278 Leads to Tumor Growth Arrest, Enhanced Sensitivity to Oxaliplatin and Vitamin D and Inhibits Metastasis via KIF5B, CYP24A1, and BTG2, Respectively. Front Oncol 2021;11:637878. [PMID: 33791222 DOI: 10.3389/fonc.2021.637878] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Okugawa Y, Toiyama Y, Goel A. An update on microRNAs as colorectal cancer biomarkers: where are we and what's next? Expert Rev Mol Diagn. 2014;14:999-1021. [PMID: 25163355 DOI: 10.1586/14737159.2014.946907] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
41 Liu F, Zhang F, Li X, Liu Q, Liu W, Song P, Qiu Z, Dong Y, Xiang H. Prognostic role of miR-17-92 family in human cancers: evaluation of multiple prognostic outcomes. Oncotarget 2017;8:69125-38. [PMID: 28978185 DOI: 10.18632/oncotarget.19096] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
42 Chen B, Xia Z, Deng YN, Yang Y, Zhang P, Zhu H, Xu N, Liang S. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis. Open Biol. 2019;9:180212. [PMID: 30958116 DOI: 10.1098/rsob.180212] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
43 Gungormez C, Gumushan Aktas H, Dilsiz N, Borazan E. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis. Mol Biol Rep 2019;46:4175-83. [PMID: 31123908 DOI: 10.1007/s11033-019-04868-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
44 Shiosaki J, Tiirikainen M, Peplowska K, Shaeffer D, Machida M, Sakamoto K, Takahashi M, Kojima K, Machi J, Bryant-Greenwood P, Kuwada SK. Serum micro-RNA Identifies Early Stage Colorectal Cancer in a Multi-Ethnic Population. Asian Pac J Cancer Prev 2020;21:3019-26. [PMID: 33112562 DOI: 10.31557/APJCP.2020.21.10.3019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Liu C, Eng C, Shen J, Lu Y, Takata Y, Mehdizadeh A, Chang GJ, Rodriguez-Bigas MA, Li Y, Chang P, Mao Y, Hassan MM, Wang F, Li D. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget. 2016;7:76250-76260. [PMID: 27788488 DOI: 10.18632/oncotarget.12841] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 14.0] [Reference Citation Analysis]
46 Xie N, Meng Q, Zhang Y, Luo Z, Xue F, Liu S, Li Y, Huang Y. MicroRNA‑142‑3p suppresses cell proliferation, invasion and epithelial‑to‑mesenchymal transition via RAC1‑ERK1/2 signaling in colorectal cancer. Mol Med Rep 2021;24:568. [PMID: 34109430 DOI: 10.3892/mmr.2021.12207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Jacob H, Stanisavljevic L, Storli KE, Hestetun KE, Dahl O, Myklebust MP. A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer. Sci Rep 2018;8:6157. [PMID: 29670141 DOI: 10.1038/s41598-018-24519-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
48 Zhang Q, Wang Q, Sun W, Gao F, Liu L, Cheng L, Li Z. Change of Circulating and Tissue-Based miR-20a in Human Cancers and Associated Prognostic Implication: A Systematic Review and Meta-Analysis. Biomed Res Int 2018;2018:6124927. [PMID: 30596096 DOI: 10.1155/2018/6124927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
49 Chen S, Lao J, Geng Q, Zhang J, Wu A, Xu D. A 3-MicroRNA Signature Identified From Serum Predicts Clinical Outcome of the Locally Advanced Gastric Cancer. Front Oncol 2020;10:565. [PMID: 32656071 DOI: 10.3389/fonc.2020.00565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Wang K, Liu Y, Lu G, Xiao J, Huang J, Lei L, Peng J, Li Y, Wei S. A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA. Cancer Med 2022;11:281-94. [PMID: 34854250 DOI: 10.1002/cam4.4431] [Reference Citation Analysis]
51 Liang H, Li Y, Luo RY, Shen FJ. MicroRNA-215 is a potential prognostic marker for cervical cancer. J Huazhong Univ Sci Technolog Med Sci 2014;34:207-12. [PMID: 24710934 DOI: 10.1007/s11596-014-1260-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
52 Pak K, Oh SO, Goh TS, Heo HJ, Han ME, Jeong DC, Lee CS, Sun H, Kang J, Choi S, Lee S, Kwon EJ, Kang JW, Kim YH. A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study. J Med Internet Res 2020;22:e16084. [PMID: 32369034 DOI: 10.2196/16084] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
53 Zhang Y, Guan B, Wu Y, Du F, Zhuang J, Yang Y, Guan G, Liu X. LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer. J Inflamm Res 2021;14:6275-92. [PMID: 34866926 DOI: 10.2147/JIR.S334096] [Reference Citation Analysis]
54 Zeng D, Zhou R, Yu Y, Luo Y, Zhang J, Sun H, Bin J, Liao Y, Rao J, Zhang Y, Liao W. Gene expression profiles for a prognostic immunoscore in gastric cancer. Br J Surg 2018;105:1338-48. [PMID: 29691839 DOI: 10.1002/bjs.10871] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 18.5] [Reference Citation Analysis]
55 Wang X, Liu Y, Niu Z, Fu R, Jia Y, Zhang L, Shao D, Du H, Hu Y, Xing X, Cheng X, Li L, Guo T, Li Z, Ji Q, Zhang L, Ji J. Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection. Sci Rep 2017;7:7515. [PMID: 28790411 DOI: 10.1038/s41598-017-07604-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
56 Chen L, Zhang K, Sun J, Tang J, Zhou J. Development and Validation of an Autophagy-Stroma-Based Microenvironment Gene Signature for Risk Stratification in Colorectal Cancer. Onco Targets Ther 2021;14:3503-15. [PMID: 34103941 DOI: 10.2147/OTT.S312003] [Reference Citation Analysis]
57 Neerincx M, Sie DL, van de Wiel MA, van Grieken NC, Burggraaf JD, Dekker H, Eijk PP, Ylstra B, Verhoef C, Meijer GA, Buffart TE, Verheul HM. MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing. Oncogenesis 2015;4:e170. [PMID: 26436952 DOI: 10.1038/oncsis.2015.29] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
58 Hu X, Wang B, Chen Q, Huang A, Fu W, Liu L, Zhang Y, Tang G, Cheng H, Ni X, Gao L, Chen J, Chen L, Zhang W, Yang J, Cao S, Yu L, Wang J. A clinical prediction model identifies a subgroup with inferior survival within intermediate risk acute myeloid leukemia. J Cancer 2021;12:4912-23. [PMID: 34234861 DOI: 10.7150/jca.57231] [Reference Citation Analysis]
59 Kostareli E, Hielscher T, Zucknick M, Baboci L, Wichmann G, Holzinger D, Mücke O, Pawlita M, Del Mistro A, Boscolo-Rizzo P, Da Mosto MC, Tirelli G, Plinkert P, Dietz A, Plass C, Weichenhan D, Hess J. Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients. Epigenetics 2016;11:61-73. [PMID: 26786582 DOI: 10.1080/15592294.2015.1137414] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
60 Zhang L, Qiao Y, Huang J, Wan D, Zhou L, Lin S, Zheng S. Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma. Front Med (Lausanne) 2020;7:556. [PMID: 33072775 DOI: 10.3389/fmed.2020.00556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
61 Zhao K, Xu L, Li F, Ao J, Jiang G, Shi R, Chen F, Luo Q. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature. Biosci Rep 2020;40:BSR20200894. [PMID: 32789471 DOI: 10.1042/BSR20200894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
62 Kim KH, Kim J, Park H, Kim H, Lee SH, Sohn I, Lee HY, Park WY. Parallel comparison and combining effect of radiomic and emerging genomic data for prognostic stratification of non-small cell lung carcinoma patients. Thorac Cancer 2020;11:2542-51. [PMID: 32700470 DOI: 10.1111/1759-7714.13568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Lu JH, Zuo ZX, Wang W, Zhao Q, Qiu MZ, Luo HY, Chen ZH, Mo HY, Wang F, Yang DD, Wang Y, Wei XL, Wu QN, Ju HQ, Xu RH, Zeng ZL. A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients. Cell Death Discov 2018;4:116. [PMID: 30588338 DOI: 10.1038/s41420-018-0133-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
64 Cekaite L, Eide PW, Lind GE, Skotheim RI, Lothe RA. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget. 2016;7:6476-6505. [PMID: 26623728 DOI: 10.18632/oncotarget.6390] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 10.2] [Reference Citation Analysis]
65 Tian X, Zhu X, Yan T, Yu C, Shen C, Hu Y, Hong J, Chen H, Fang JY. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer. Mol Oncol 2017;11:1544-60. [PMID: 28796930 DOI: 10.1002/1878-0261.12117] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
66 Fu F, Jiang W, Zhou L, Chen Z. Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer. Transl Oncol. 2018;11:221-232. [PMID: 29367070 DOI: 10.1016/j.tranon.2017.12.012] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 19.5] [Reference Citation Analysis]
67 Della Vittoria Scarpati G, Calura E, Di Marino M, Romualdi C, Beltrame L, Malapelle U, Troncone G, De Stefano A, Pepe S, De Placido S, D'Incalci M, Marchini S, Carlomagno C. Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients. Biomed Res Int 2014;2014:840921. [PMID: 25143946 DOI: 10.1155/2014/840921] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
68 Wang X, Liu Y, Leng X, Cao K, Sun W, Zhu J, Ma J. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma. Pathol Oncol Res 2021;27:632531. [PMID: 34257599 DOI: 10.3389/pore.2021.632531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Zhang L, Li Y, Dai Y, Wang D, Wang X, Cao Y, Liu W, Tao Z. Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma. Sci Rep 2021;11:18875. [PMID: 34556750 DOI: 10.1038/s41598-021-98381-2] [Reference Citation Analysis]
70 Papadaki C, Stoupis G, Tsalikis L, Monastirioti A, Papadaki M, Maliotis N, Stratigos M, Mastrostamatis G, Mavroudis D, Agelaki S. Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer. Oncotarget 2019;10:966-81. [PMID: 30847025 DOI: 10.18632/oncotarget.26629] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
71 Chen D, Liu Z, Liu W, Fu M, Jiang W, Xu S, Wang G, Chen F, Lu J, Chen H, Dong X, Li G, Chen G, Zhuo S, Yan J. Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram. Nat Commun 2021;12:179. [PMID: 33420057 DOI: 10.1038/s41467-020-20429-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
72 Liu Q, Li J, Xu L, Wang J, Zeng Z, Fu J, Huang X, Chu Y, Wang J, Zhang HY, Zeng F. Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach. Front Oncol 2021;11:620945. [PMID: 33996544 DOI: 10.3389/fonc.2021.620945] [Reference Citation Analysis]
73 Duan JL, Nie RC, Xiang ZC, Chen JW, Deng MH, Liang H, Wang FW, Luo RZ, Xie D, Cai MY. Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications. J Hepatocell Carcinoma 2021;8:493-505. [PMID: 34095004 DOI: 10.2147/JHC.S309451] [Reference Citation Analysis]
74 Zhang L, Cui H, Chen Q, Li Y, Yang C, Yang Y. A web-based dynamic Nomogram for predicting instrumental activities of daily living disability in older adults: a nationally representative survey in China. BMC Geriatr 2021;21:311. [PMID: 34001030 DOI: 10.1186/s12877-021-02223-9] [Reference Citation Analysis]
75 Niedzwiecki D, Frankel WL, Venook AP, Ye X, Friedman PN, Goldberg RM, Mayer RJ, Colacchio TA, Mulligan JM, Davison TS, O'Brien E, Kerr P, Johnston PG, Kennedy RD, Harkin DP, Schilsky RL, Bertagnolli MM, Warren RS, Innocenti F. Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance). J Clin Oncol 2016;34:3047-53. [PMID: 27432924 DOI: 10.1200/JCO.2015.65.4699] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
76 Li Y, Yao Q, Zhang L, Mo S, Cai S, Huang D, Peng J. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer. Oncologist 2020;25:e1968-79. [PMID: 32926498 DOI: 10.1002/ONCO.13521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Zhang GJ, Li JS, Zhou H, Xiao HX, Li Y, Zhou T. MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1. J Exp Clin Cancer Res. 2015;34:73. [PMID: 26223867 DOI: 10.1186/s13046-015-0189-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
78 Tian X, Zhu X, Yan T, Yu C, Shen C, Hong J, Chen H, Fang JY. Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis. J Cancer 2017;8:2575-86. [PMID: 28900495 DOI: 10.7150/jca.19980] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
79 Hang J, Wei F, Yan Z, Zhang X, Xu K, Zhu Y. The value of miR-510 in the prognosis and development of colon cancer. Open Med (Wars) 2021;16:795-804. [PMID: 34036176 DOI: 10.1515/med-2021-0251] [Reference Citation Analysis]
80 Li R, Wang G, Wu Z, Lu H, Li G, Sun Q, Cai M. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis. Exp Biol Med (Maywood) 2021;246:1512-23. [PMID: 33563042 DOI: 10.1177/1535370221992015] [Reference Citation Analysis]
81 Fang W, Guo J, Cao Y, Wang S, Pang C, Li M, Dou L, Man Y, Huang X, Shen T, Li J. MicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression. J Cell Mol Med 2016;20:1467-80. [PMID: 27019188 DOI: 10.1111/jcmm.12835] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
82 Bai F, Zhou H, Ma M, Guan C, Lyu J, Meng QH. A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma. Mol Oncol 2018;12:1125-37. [PMID: 29719937 DOI: 10.1002/1878-0261.12315] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
83 Huang L, Wang X, Wen C, Yang X, Song M, Chen J, Wang C, Zhang B, Wang L, Iwamoto A, Wang J, Liu H. Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer. Sci Rep 2015;5:13350. [PMID: 26302825 DOI: 10.1038/srep13350] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
84 Wang M, Jing X, Cao W, Zeng Y, Wu C, Zeng W, Chen W, Hu X, Zhou Y, Cai X. A non-lab nomogram of survival prediction in home hospice care patients with gastrointestinal cancer. BMC Palliat Care 2020;19:185. [PMID: 33287827 DOI: 10.1186/s12904-020-00690-2] [Reference Citation Analysis]
85 Hoey C, Ahmed M, Fotouhi Ghiam A, Vesprini D, Huang X, Commisso K, Commisso A, Ray J, Fokas E, Loblaw DA, He HH, Liu SK. Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy. J Transl Med 2019;17:173. [PMID: 31122242 DOI: 10.1186/s12967-019-1920-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
86 Moody L, Dvoretskiy S, An R, Mantha S, Pan YX. The Efficacy of miR-20a as a Diagnostic and Prognostic Biomarker for Colorectal Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) 2019;11:E1111. [PMID: 31382594 DOI: 10.3390/cancers11081111] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
87 Li XH, Wang EL, Zhou HM, Yoshimoto K, Qian ZR. MicroRNAs in Human Pituitary Adenomas. Int J Endocrinol 2014;2014:435171. [PMID: 25548562 DOI: 10.1155/2014/435171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
88 Ouyang Z, Li G, Zhu H, Wang J, Qi T, Qu Q, Tu C, Qu J, Lu Q. Construction of a Five-Super-Enhancer-Associated-Genes Prognostic Model for Osteosarcoma Patients. Front Cell Dev Biol 2020;8:598660. [PMID: 33195283 DOI: 10.3389/fcell.2020.598660] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
89 Wang Y, Deng H, Xin S, Zhang K, Shi R, Bao X. Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma. Front Genet 2019;10:349. [PMID: 31105737 DOI: 10.3389/fgene.2019.00349] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
90 Cheng JL, Li DJ, Lv MY, Pei YJ, Zhang XJ, Li L, Liu XY, Fan AH. LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149. Cancer Gene Ther 2021;28:850-63. [PMID: 32753631 DOI: 10.1038/s41417-020-0203-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Wang R, Xu J, Liu H, Zhao Z. Peripheral leukocyte microRNAs as novel biomarkers for COPD. Int J Chron Obstruct Pulmon Dis 2017;12:1101-12. [PMID: 28435243 DOI: 10.2147/COPD.S130416] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
92 Wang L, Su M, Zhang M, Zhao H, Wang H, Xing J, Guo C, Zhou D, Xue W, Lu H, Zhang Y. Accurate Prediction of Prognosis by Integrating Clinical and Molecular Characteristics in Colon Cancer. Front Cell Dev Biol 2021;9:664415. [PMID: 34095132 DOI: 10.3389/fcell.2021.664415] [Reference Citation Analysis]
93 Dai X, Kaushik AC, Zhang J. The Emerging Role of Major Regulatory RNAs in Cancer Control. Front Oncol. 2019;9:920. [PMID: 31608229 DOI: 10.3389/fonc.2019.00920] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
94 Valassi E, García-Giralt N, Malouf J, Crespo I, Llauger J, Díez-Pérez A, Webb SM. Circulating miR-103a-3p and miR-660-5p are associated with bone parameters in patients with controlled acromegaly. Endocr Connect 2019;8:39-49. [PMID: 30640713 DOI: 10.1530/EC-18-0482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
95 Guo L, Yuan J, Xie N, Wu H, Chen W, Song S, Wang X. miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer. Mol Med Rep 2016;14:2975-82. [PMID: 27572271 DOI: 10.3892/mmr.2016.5645] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
96 Rammer M, Webersinke G, Haitchi-Petnehazy S, Maier E, Hackl H, Charoentong P, Malli T, Steinmair M, Petzer AL, Rumpold H. MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma. Clin Exp Metastasis 2017;34:431-40. [PMID: 29134398 DOI: 10.1007/s10585-017-9863-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
97 Fan S, Cui X, Liu C, Li X, Zheng L, Song Q, Qi J, Ma W, Ye Z. CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer. Front Oncol 2021;11:644933. [PMID: 33816297 DOI: 10.3389/fonc.2021.644933] [Reference Citation Analysis]
98 Boland CR, Goel A. Prognostic Subgroups among Patients with Stage II Colon Cancer. N Engl J Med 2016;374:277-8. [PMID: 26789877 DOI: 10.1056/NEJMe1514353] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
99 Zheng Y, Li S, Boohaker RJ, Liu X, Zhu Y, Zhai L, Li H, Gu F, Fan Y, Lang R, Liu F, Qian X, Xu B, Fu L. A MicroRNA Expression Signature In Taxane-anthracycline-Based Neoadjuvant Chemotherapy Response. J Cancer 2015;6:671-7. [PMID: 26078798 DOI: 10.7150/jca.11616] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
100 Hu C, Cao Y, Li P, Tang X, Yang M, Gu S, Xiong K, Li T, Xiao T. Oleanolic Acid Induces Autophagy and Apoptosis via the AMPK-mTOR Signaling Pathway in Colon Cancer. J Oncol 2021;2021:8281718. [PMID: 34326874 DOI: 10.1155/2021/8281718] [Reference Citation Analysis]
101 Liang G, Li Y, Feng W, Wang X, Jing A, Li J, Ma K. Polyethyleneimine-coated quantum dots for miRNA delivery and its enhanced suppression in HepG2 cells. Int J Nanomedicine 2016;11:6079-88. [PMID: 27895481 DOI: 10.2147/IJN.S120828] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
102 Pan YB, Zhu Y, Zhang QW, Zhang CH, Shao A, Zhang J. Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis. Front Oncol 2020;10:1057. [PMID: 32793467 DOI: 10.3389/fonc.2020.01057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
103 Li G, Jiang Y, Lyu X, Cai Y, Zhang M, Li G, Qiao Q. Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma. J Cell Mol Med 2020;24:4726-35. [PMID: 32160398 DOI: 10.1111/jcmm.15145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
104 Kawahara D, Imano N, Nishioka R, Ogawa K, Kimura T, Nakashima T, Iwamoto H, Fujitaka K, Hattori N, Nagata Y. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis. Sci Rep 2021;11:16232. [PMID: 34376721 DOI: 10.1038/s41598-021-95643-x] [Reference Citation Analysis]
105 Huang K, Sun H, Li X, Hu T, Yang R, Wang S, Jia Y, Chen Z, Tang F, Shen J, Qin X, Zhou H, Yang R, Gui J, Wang L, Zhao X, Zhang J, Liu J, Guo L, Li S, Wang S. Prognostic risk model development and prospective validation among patients with cervical cancer stage IB2 to IIB submitted to neoadjuvant chemotherapy. Sci Rep 2016;6:27568. [PMID: 27279023 DOI: 10.1038/srep27568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
106 Ding T, Cui P, Zhou Y, Chen C, Zhao J, Wang H, Guo M, He Z, Xu L. Antisense Oligonucleotides against miR-21 Inhibit the Growth and Metastasis of Colorectal Carcinoma via the DUSP8 Pathway. Mol Ther Nucleic Acids 2018;13:244-55. [PMID: 30317164 DOI: 10.1016/j.omtn.2018.09.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
107 Wang Y, Yang Z. A Gleason score-related outcome model for human prostate cancer: a comprehensive study based on weighted gene co-expression network analysis. Cancer Cell Int 2020;20:159. [PMID: 32425694 DOI: 10.1186/s12935-020-01230-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
108 Teng H, Mao F, Liang J, Xue M, Wei W, Li X, Zhang K, Feng D, Liu B, Sun Z. Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma. Theranostics. 2018;8:4345-4358. [PMID: 30214625 DOI: 10.7150/thno.26862] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
109 Lan H, Lu H, Wang X, Jin H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int 2015;2015:125094. [PMID: 25874201 DOI: 10.1155/2015/125094] [Cited by in Crossref: 127] [Cited by in F6Publishing: 149] [Article Influence: 18.1] [Reference Citation Analysis]
110 Zhu B, Zhang P, Liu M, Jiang C, Liu H, Fu J. Prognostic Significance of CSN2, CD8, and MMR Status-Associated Nomograms in Patients with Colorectal Cancer. Transl Oncol 2018;11:1202-12. [PMID: 30075461 DOI: 10.1016/j.tranon.2018.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
111 Xue F, Yang L, Dai B, Xue H, Zhang L, Ge R, Sun Y. Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma. PeerJ 2020;8:e8301. [PMID: 32518711 DOI: 10.7717/peerj.8301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
112 Cai H, Pang X, Dong D, Ma Y, Huang Y, Fan X, Wu P, Chen H, He F, Cheng Y, Liu S, Yu Y, Hong M, Xiao J, Wan X, Lv Y, Zheng J. Molecular Decision Tree Algorithms Predict Individual Recurrence Pattern for Locally Advanced Nasopharyngeal Carcinoma. J Cancer 2019;10:3323-32. [PMID: 31293635 DOI: 10.7150/jca.29693] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Huang Q, Qu T, Qi L, Liu C, Guo Y, Guo Q, Li G, Wang Y, Zhang W, Zhao W, Ren D, Sun L, Wang S, Meng B, Sun B, Zhang B, Ma W, Cao W. A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma. Cancer Biol Med 2021:j. [PMID: 33710816 DOI: 10.20892/j.issn.2095-3941.2020.0648] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Wang X, Li C, Chen T, Li W, Zhang H, Zhang D, Liu Y, Han D, Li Y, Li Z, Luo D, Zhang N, Yang Q. Identification and Validation of a Five-Gene Signature Associated With Overall Survival in Breast Cancer Patients. Front Oncol 2021;11:660242. [PMID: 34513664 DOI: 10.3389/fonc.2021.660242] [Reference Citation Analysis]
115 Wang G, Chang Y, Wu X, Li X, Li L, Zhang M. Prognostic nomogram for overall survival in upper aerodigestive tract extranodal natural killer/T-cell lymphoma, nasal type, stages IE and IIE: A SEER-based study. Oncol Lett 2019;18:3493-500. [PMID: 31516567 DOI: 10.3892/ol.2019.10719] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
116 Pan C, Wang X, Chen W, Tao C, Xu X, Jin L, Chen Y, Zhu L, Zhou L, Pan Z. Reevaluation of glypican-3 as a prognostic marker in HCC using X-tile software. Med Oncol. 2015;32:359. [PMID: 25432695 DOI: 10.1007/s12032-014-0359-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
117 Liu Y, Huang A, Chen Q, Chen X, Fei Y, Zhao X, Zhang W, Hong Z, Zhu Z, Yang J, Chai Y, Wang J, Hu X. A distinct glycerophospholipid metabolism signature of acute graft versus host disease with predictive value. JCI Insight 2019;5:129494. [PMID: 31343987 DOI: 10.1172/jci.insight.129494] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
118 Yamazaki N, Koga Y, Taniguchi H, Kojima M, Kanemitsu Y, Saito N, Matsumura Y. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer. Oncotarget. 2017;8:6970-6983. [PMID: 28036302 DOI: 10.18632/oncotarget.14344] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
119 Tian M, Liu W, Tao C, Tang Z, Zhou Y, Song S, Jin L, Wang H, Jiang X, Zhou P, Fang Y, Qu W, Ding Z, Peng Y, Fu X, Qiu S, Zhou J, Fan J, Shi Y. Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: ISICC -applied prediction model. Cancer Sci 2020;111:1084-92. [PMID: 31971309 DOI: 10.1111/cas.14315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
120 Battistella M, Romero M, Castro-Vega LJ, Gapihan G, Bouhidel F, Bagot M, Feugeas JP, Janin A. The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression. J Invest Dermatol 2015;135:1659-67. [PMID: 25634356 DOI: 10.1038/jid.2015.27] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
121 Jiang Y, Wang W, Chen C, Zhang X, Zha X, Lv W, Xie J, Huang W, Sun Z, Hu Y, Yu J, Li T, Zhou Z, Xu Y, Li G. Radiomics Signature on Computed Tomography Imaging: Association With Lymph Node Metastasis in Patients With Gastric Cancer. Front Oncol 2019;9:340. [PMID: 31106158 DOI: 10.3389/fonc.2019.00340] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
122 Li JL, Li KZ, Xie MZ, Tang YP, Tang YL, Hu B. Clinical Significance and Prognostic Value of miR-28-5p in Colon Cancer. Dis Markers 2020;2020:3159831. [PMID: 32566038 DOI: 10.1155/2020/3159831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Pichler M, Stiegelbauer V, Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X, Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, Haybaeck J, Svoboda M, Okugawa Y, Gerger A, Hoefler G, Goel A, Slaby O, Calin GA. Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis. Clin Cancer Res 2017;23:1323-33. [PMID: 27601590 DOI: 10.1158/1078-0432.CCR-16-0497] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
124 Wang H, Wu L, Wang H. Development and verification of a personalized immune prognostic feature in breast cancer. Exp Biol Med (Maywood) 2020;245:1242-53. [PMID: 32600059 DOI: 10.1177/1535370220936964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Shi G, Zhang J, Lu Z, Liu D, Wu Y, Wu P, Yin J, Yuan H, Zhu Q, Chen L, Fu Y, Peng Y, Wang Y, Jiang K, Miao Y. A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma. Oncotarget 2017;8:110849-60. [PMID: 29340021 DOI: 10.18632/oncotarget.22861] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
126 Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol 2015;16:e173-80. [PMID: 25846097 DOI: 10.1016/S1470-2045(14)71116-7] [Cited by in Crossref: 678] [Cited by in F6Publishing: 503] [Article Influence: 96.9] [Reference Citation Analysis]
127 Liu Q, Wang K, Huang R, Tong X, Jiang T, Wang J, Yang P. A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level. J Cancer Res Clin Oncol 2020;146:579-91. [PMID: 32060643 DOI: 10.1007/s00432-020-03132-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Chen D, Chen H, Chi L, Fu M, Wang G, Wu Z, Xu S, Sun C, Xu X, Lin L, Cheng J, Jiang W, Dong X, Lu J, Zheng J, Chen G, Li G, Zhuo S, Yan J. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer. JAMA Netw Open 2021;4:e2136388. [PMID: 34846524 DOI: 10.1001/jamanetworkopen.2021.36388] [Reference Citation Analysis]
129 Jiang R, Chen X, Ge S, Wang Q, Liu Y, Chen H, Xu J, Wu J. MiR-21-5p Induces Pyroptosis in Colorectal Cancer via TGFBI. Front Oncol 2020;10:610545. [PMID: 33614494 DOI: 10.3389/fonc.2020.610545] [Reference Citation Analysis]
130 Wu W, Li D, Ma W, Zheng S, Han D, Xu F, Yan H, Lyu J. Examining More Lymph Nodes May Improve the Prognosis of Patients With Right Colon Cancer: Determining the Optimal Minimum Lymph Node Count. Cancer Control 2021;28:10732748211064034. [PMID: 34928724 DOI: 10.1177/10732748211064034] [Reference Citation Analysis]
131 Cai M, Yao F, Ding J, Zheng R, Huang X, Yang Y, Lin F, Hu Z. MRI Radiomic Features: A Potential Biomarker for Progression-Free Survival Prediction of Patients With Locally Advanced Cervical Cancer Undergoing Surgery. Front Oncol 2021;11:749114. [PMID: 34970482 DOI: 10.3389/fonc.2021.749114] [Reference Citation Analysis]
132 Wang L, Li X. Identification of an energy metabolism‑related gene signature in ovarian cancer prognosis. Oncol Rep 2020;43:1755-70. [PMID: 32186777 DOI: 10.3892/or.2020.7548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
133 Kuang Z, Li X, Liu R, Chen S, Tu J. Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature. Front Cell Dev Biol 2021;9:648856. [PMID: 34079795 DOI: 10.3389/fcell.2021.648856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Mo X, Zhou M, Yan H, Chen X, Wang Y. Competing risk analysis of cardiovascular/cerebrovascular death in T1/2 kidney cancer: a SEER database analysis. BMC Cancer 2021;21:13. [PMID: 33402111 DOI: 10.1186/s12885-020-07718-z] [Reference Citation Analysis]
135 Chalbatani GM, Momeni SA, Mohammadi Hadloo MH, Karimi Z, Hadizadeh M, Jalali SA, Miri SR, Memari F, Hamblin MR. Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma. Comput Biol Med 2021;:105043. [PMID: 34839901 DOI: 10.1016/j.compbiomed.2021.105043] [Reference Citation Analysis]
136 Zhao E, Lan Y, Quan F, Zhu X, A S, Wan L, Xu J, Hu J. Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients. Front Genet 2020;11:673. [PMID: 32849766 DOI: 10.3389/fgene.2020.00673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
137 Falzone L, Scola L, Zanghì A, Biondi A, Di Cataldo A, Libra M, Candido S. Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development. Aging (Albany NY) 2018;10:1000-14. [PMID: 29779016 DOI: 10.18632/aging.101444] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 27.3] [Reference Citation Analysis]
138 Shi M, Mu Y, Zhang H, Liu M, Wan J, Qin X, Li C. MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis. Medicine (Baltimore) 2018;97:e11505. [PMID: 30095616 DOI: 10.1097/MD.0000000000011505] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
139 Luo R, Guo W, Wang H. A comprehensive analysis of tumor microenvironment-related genes in colon cancer. Clin Transl Oncol 2021;23:1769-81. [PMID: 33689097 DOI: 10.1007/s12094-021-02578-w] [Reference Citation Analysis]
140 Liu B, Zhou M, Li X, Zhang X, Wang Q, Liu L, Yang M, Yang D, Guo Y, Zhang Q, Zheng H, Wang Q, Li L, Chu X, Wang W, Li H, Song F, Pan Y, Zhang W, Chen K. Interrogation of gender disparity uncovers androgen receptor as the transcriptional activator for oncogenic miR-125b in gastric cancer. Cell Death Dis 2021;12:441. [PMID: 33947843 DOI: 10.1038/s41419-021-03727-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
141 Cheng D, Zhao S, Tang H, Zhang D, Sun H, Yu F, Jiang W, Yue B, Wang J, Zhang M, Yu Y, Liu X, Sun X, Zhou Z, Qin X, Zhang X, Yan D, Wen Y, Peng Z. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4. Oncotarget 2016;7:45199-213. [PMID: 27286257 DOI: 10.18632/oncotarget.9900] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 14.8] [Reference Citation Analysis]
142 Liang Y, Li J, Li Q, Tang L, Chen L, Mao Y, He Q, Yang X, Lei Y, Hong X, Zhao Y, He S, Guo Y, Wang Y, Zhang P, Liu N, Li Y, Ma J. Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma. Theranostics 2020;10:9767-78. [PMID: 32863958 DOI: 10.7150/thno.47882] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
143 Liu F, Xing L, Zhang X, Zhang X. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma. Genes (Basel) 2019;10:E414. [PMID: 31146489 DOI: 10.3390/genes10060414] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
144 Zhao S, Yao D, Chen J, Ding N, Ren F. MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo. PLoS One 2015;10:e0120905. [PMID: 25803820 DOI: 10.1371/journal.pone.0120905] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
145 Tian B, Hou M, Zhou K, Qiu X, Du Y, Gu Y, Yin X, Wang J. A Novel TCGA-Validated, MiRNA-Based Signature for Prediction of Breast Cancer Prognosis and Survival. Front Cell Dev Biol 2021;9:717462. [PMID: 34589485 DOI: 10.3389/fcell.2021.717462] [Reference Citation Analysis]
146 Liu Z, Liu X, Li Y, Ren P, Zhang C, Wang L, Du X, Xing B. miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression. Cancer Manag Res 2019;11:5317-32. [PMID: 31239781 DOI: 10.2147/CMAR.S197733] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
147 Feng Q, Hu Q, Liu Y, Yang T, Yin Z. Diagnosis of triple negative breast cancer based on radiomics signatures extracted from preoperative contrast-enhanced chest computed tomography. BMC Cancer 2020;20:579. [PMID: 32571245 DOI: 10.1186/s12885-020-07053-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Huang FT, Chen WY, Gu ZQ, Zhuang YY, Li CQ, Wang LY, Peng JF, Zhu Z, Luo X, Li YH, Yao HR, Zhang SN. The novel long intergenic noncoding RNA UCC promotes colorectal cancer progression by sponging miR-143. Cell Death Dis 2017;8:e2778. [PMID: 28492554 DOI: 10.1038/cddis.2017.191] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
149 Toraih EA, Fawzy MS, Hussein MH, El-Labban MM, Ruiz EML, Attia AA, Halat S, Moroz K, Errami Y, Zerfaoui M, Kandil E. MicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Matched Analysis. Cancers (Basel) 2021;13:4649. [PMID: 34572876 DOI: 10.3390/cancers13184649] [Reference Citation Analysis]
150 Ozawa T, Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Hata K, Kawai K, Nozawa H, Kazama S. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer. Int J Colorectal Dis. 2015;30:1165-1171. [PMID: 26049902 DOI: 10.1007/s00384-015-2276-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
151 Meng J, Zhang J, Xiu Y, Jin Y, Xiang J, Nie Y, Fu S, Zhao K. Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy. Mol Oncol 2018;12:196-207. [PMID: 29160958 DOI: 10.1002/1878-0261.12158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
152 Guo HL, Lu XZ, Hu HT, Ruan SM, Zheng X, Xie XY, Lu MD, Kuang M, Shen SL, Chen LD, Wang W. Contrast-Enhanced Ultrasound-Based Nomogram: A Potential Predictor of Individually Postoperative Early Recurrence for Patients With Combined Hepatocellular-Cholangiocarcinoma. J Ultrasound Med 2021. [PMID: 34751450 DOI: 10.1002/jum.15869] [Reference Citation Analysis]
153 Chen Z, Liu H, Jin W, Ding Z, Zheng S, Yu Y. Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer - a meta-analysis. Onco Targets Ther. 2016;9:2615-2624. [PMID: 27226723 DOI: 10.2147/ott.s103893] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
154 Victoria Martinez B, Dhahbi JM, Nunez Lopez YO, Lamperska K, Golusinski P, Luczewski L, Kolenda T, Atamna H, Spindler SR, Golusinski W, Masternak MM. Circulating small non-coding RNA signature in head and neck squamous cell carcinoma. Oncotarget 2015;6:19246-63. [PMID: 26057471 DOI: 10.18632/oncotarget.4266] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 8.5] [Reference Citation Analysis]
155 Di Z, Di M, Fu W, Tang Q, Liu Y, Lei P, Gu X, Liu T, Sun M. Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer. Front Genet 2020;11:192. [PMID: 32265979 DOI: 10.3389/fgene.2020.00192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
156 González N, Prieto I, Del Puerto-Nevado L, Portal-Nuñez S, Ardura JA, Corton M, Fernández-Fernández B, Aguilera O, Gomez-Guerrero C, Mas S, Moreno JA, Ruiz-Ortega M, Sanz AB, Sanchez-Niño MD, Rojo F, Vivanco F, Esbrit P, Ayuso C, Alvarez-Llamas G, Egido J, García-Foncillas J, Ortiz A; DiabetesCancerConnect Consortium. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget 2017;8:18456-85. [PMID: 28060743 DOI: 10.18632/oncotarget.14472] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
157 Zhu X, Tian X, Sun T, Yu C, Cao Y, Yan T, Shen C, Lin Y, Fang JY, Hong J, Chen H. GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer. Mol Oncol 2018;12:1871-83. [PMID: 29957874 DOI: 10.1002/1878-0261.12351] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
158 Li W, Chang J, Wang S, Liu X, Peng J, Huang D, Sun M, Chen Z, Zhang W, Guo W. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Oncotarget. 2015;6:24448-24462. [PMID: 26259252 DOI: 10.18632/oncotarget.4423] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 8.2] [Reference Citation Analysis]
159 Okuyama T, Sameshima S, Takeshita E, Mitsui T, Noro T, Ono Y, Noie T, Ban S, Oya M. Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer. BMC Cancer 2020;20:842. [PMID: 32883261 DOI: 10.1186/s12885-020-07335-w] [Reference Citation Analysis]
160 Kim YH, Jeong DC, Pak K, Goh TS, Lee CS, Han ME, Kim JY, Liangwen L, Kim CD, Jang JY, Cha W, Oh SO. Gene network inherent in genomic big data improves the accuracy of prognostic prediction for cancer patients. Oncotarget 2017;8:77515-26. [PMID: 29100405 DOI: 10.18632/oncotarget.20548] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
161 Zhang Y, Wu X, Zhang C, Wang J, Fei G, Di X, Lu X, Feng L, Cheng S, Yang A. Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis. J Pathol 2020;251:135-46. [PMID: 32207854 DOI: 10.1002/path.5434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
162 Xiao Z, Chen S, Feng S, Li Y, Zou J, Ling H, Zeng Y, Zeng X. Function and mechanisms of microRNA-20a in colorectal cancer. Exp Ther Med 2020;19:1605-16. [PMID: 32104211 DOI: 10.3892/etm.2020.8432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
163 Zhao S, Tang H, Yan D, Fan J, Sun H, Wen Y, Yu F, Cui F, Zhang D, Xue Y, Liu C, Yue B, Chen J, Wang J, Wang X, Zhang M, Yu Y, Jiang W, Liu X, Mi Y, Zhou Z, Qin X, Peng Z. DDA1 promotes stage IIB-IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling. Oncotarget 2016;7:19794-812. [PMID: 26942699 DOI: 10.18632/oncotarget.7847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
164 Li H, Liu J, Chen J, Wang H, Yang L, Chen F, Fan S, Wang J, Shao B, Yin D, Zeng M, Li M, Li J, Su F, Liu Q, Yao H, Su S, Song E. A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients. Nat Commun 2018;9:1614. [PMID: 29691399 DOI: 10.1038/s41467-018-03537-w] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 12.5] [Reference Citation Analysis]
165 Peng Q, Shen Y, Zhao P, Cheng M, Zhu Y, Xu B. Biomarker roles identification of miR-106 family for predicting the risk and poor survival of colorectal cancer. BMC Cancer 2020;20:506. [PMID: 32493303 DOI: 10.1186/s12885-020-06863-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
166 Boakye D, Jansen L, Schneider M, Chang-Claude J, Hoffmeister M, Brenner H. Personalizing the Prediction of Colorectal Cancer Prognosis by Incorporating Comorbidities and Functional Status into Prognostic Nomograms. Cancers (Basel) 2019;11:E1435. [PMID: 31561507 DOI: 10.3390/cancers11101435] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
167 Zeng Z, Yang F, Wang Y, Zhao H, Wei F, Zhang P, Zhang X, Ren X. Significantly different immunoscores in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system. Oncoimmunology 2020;9:1828538. [PMID: 33101777 DOI: 10.1080/2162402X.2020.1828538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
168 Kang WK, Lee JK, Oh ST, Lee SH, Jung CK. Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse. BMC Gastroenterol 2015;15:2. [PMID: 25609245 DOI: 10.1186/s12876-015-0227-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
169 Luo XJ, Zhao Q, Liu J, Zheng JB, Qiu MZ, Ju HQ, Xu RH. Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer. Mol Ther 2021;29:587-96. [PMID: 33333293 DOI: 10.1016/j.ymthe.2020.12.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
170 Lin HH, Wei NC, Chou TY, Lin CC, Lan YT, Chang SC, Wang HS, Yang SH, Chen WS, Lin TC, Lin JK, Jiang JK. Building personalized treatment plans for early-stage colorectal cancer patients. Oncotarget 2017;8:13805-17. [PMID: 28099153 DOI: 10.18632/oncotarget.14638] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
171 Tang J, Zhuo H, Zhang X, Jiang R, Ji J, Deng L, Qian X, Zhang F, Sun B. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma. Cell Death Dis. 2014;5:e1549. [PMID: 25476897 DOI: 10.1038/cddis.2014.518] [Cited by in Crossref: 114] [Cited by in F6Publishing: 121] [Article Influence: 14.3] [Reference Citation Analysis]
172 Jiang Y, Yuan Q, Lv W, Xi S, Huang W, Sun Z, Chen H, Zhao L, Liu W, Hu Y, Lu L, Ma J, Li T, Yu J, Wang Q, Li G. Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits. Theranostics. 2018;8:5915-5928. [PMID: 30613271 DOI: 10.7150/thno.28018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 10.3] [Reference Citation Analysis]
173 Viswanathan V, Opdenaker L, Modarai S, Fields JZ, Gonye G, Boman BM. MicroRNA Expression Profiling of Normal and Malignant Human Colonic Stem Cells Identifies miRNA92a as a Regulator of the LRIG1 Stem Cell Gene. Int J Mol Sci 2020;21:E2804. [PMID: 32316543 DOI: 10.3390/ijms21082804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
174 Cheng Q, Li X, Acharya CR, Hyslop T, Sosa JA. A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors. Oncotarget 2017;8:16690-703. [PMID: 28187428 DOI: 10.18632/oncotarget.15128] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
175 Wei JH, Haddad A, Wu KJ, Zhao HW, Kapur P, Zhang ZL, Zhao LY, Chen ZH, Zhou YY, Zhou JC, Wang B, Yu YH, Cai MY, Xie D, Liao B, Li CX, Li PX, Wang ZR, Zhou FJ, Shi L, Liu QZ, Gao ZL, He DL, Chen W, Hsieh JT, Li QZ, Margulis V, Luo JH. A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun 2015;6:8699. [PMID: 26515236 DOI: 10.1038/ncomms9699] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 7.7] [Reference Citation Analysis]
176 Poel D, Buffart TE, Oosterling-Jansen J, Verheul HM, Voortman J. Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer. Exp Mol Med 2018;50:e454. [PMID: 29520111 DOI: 10.1038/emm.2017.288] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
177 Lai J, Chen B, Zhang G, Li X, Mok H, Liao N. Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature. J Transl Med 2020;18:416. [PMID: 33160384 DOI: 10.1186/s12967-020-02578-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
178 Boussios S, Ozturk MA, Moschetta M, Karathanasi A, Zakynthinakis-Kyriakou N, Katsanos KH, Christodoulou DK, Pavlidis N. The Developing Story of Predictive Biomarkers in Colorectal Cancer. J Pers Med 2019;9:E12. [PMID: 30736475 DOI: 10.3390/jpm9010012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 15.3] [Reference Citation Analysis]
179 Guo JC, Zhang P, Zhou L, You L, Liu QF, Zhang ZG, Sun B, Liang ZY, Lu J, Yuan D, Tan AD, Sun J, Liao Q, Dai MH, Xiao GG, Li S, Zhang TP. Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study. EBioMedicine 2020;55:102767. [PMID: 32361251 DOI: 10.1016/j.ebiom.2020.102767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Xing L, Zhang X, Chen A. Prognostic 4-lncRNA-based risk model predicts survival time of patients with head and neck squamous cell carcinoma. Oncol Lett 2019;18:3304-16. [PMID: 31452809 DOI: 10.3892/ol.2019.10670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
181 Zhang F, Liu Y, Yang Y, Yang K. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. BMC Cancer 2020;20:1015. [PMID: 33081731 DOI: 10.1186/s12885-020-07489-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
182 Li J, Zhang Z, Hu J, Wan X, Huang W, Zhang H, Jiang N. MiR-1246 regulates the PI3K/AKT signaling pathway by targeting PIK3AP1 and inhibits thyroid cancer cell proliferation and tumor growth. Mol Cell Biochem 2021. [PMID: 34870753 DOI: 10.1007/s11010-021-04290-3] [Reference Citation Analysis]
183 Feng YH, Tsao CJ. Emerging role of microRNA-21 in cancer. Biomed Rep 2016;5:395-402. [PMID: 27699004 DOI: 10.3892/br.2016.747] [Cited by in Crossref: 179] [Cited by in F6Publishing: 185] [Article Influence: 29.8] [Reference Citation Analysis]
184 Li Y, Ge D, Gu J, Xu F, Zhu Q, Lu C. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies. BMC Cancer 2019;19:886. [PMID: 31488089 DOI: 10.1186/s12885-019-6101-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
185 Li Z, Li S, Liang Y, Pu H, Tu C, Wu Z, You D. Predictive Value of Postoperative Peripheral CD4+ T Cells Percentage in Stage I-III Colorectal Cancer: A Retrospective Multicenter Cohort Study of 1028 Subjects. Cancer Manag Res 2020;12:5505-13. [PMID: 32753965 DOI: 10.2147/CMAR.S259464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
186 Zhang K, Zhang L, Zhang M, Zhang Y, Fan D, Jiang J, Ye L, Fang X, Chen X, Fan S, Chao M, Liang C. Prognostic value of high-expression of miR-17-92 cluster in various tumors: evidence from a meta-analysis. Sci Rep 2017;7:8375. [PMID: 28827775 DOI: 10.1038/s41598-017-08349-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
187 Wang L, Shen X, Wang Z, Xiao X, Wei P, Wang Q, Ren F, Wang Y, Liu Z, Sheng W, Huang W, Zhou X, Du X. A molecular signature for the prediction of recurrence in colorectal cancer. Mol Cancer 2015;14:22. [PMID: 25645394 DOI: 10.1186/s12943-015-0296-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
188 Lai J, Chen B, Zhang G, Wang Y, Mok H, Wen L, Pan Z, Su F, Liao N. Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer. Aging (Albany NY) 2019;11:7525-36. [PMID: 31548433 DOI: 10.18632/aging.102268] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
189 Chen LD, Ruan SM, Liang JY, Yang Z, Shen SL, Huang Y, Li W, Wang Z, Xie XY, Lu MD, Kuang M, Wang W. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound. World J Gastroenterol 2018; 24(33): 3786-3798 [PMID: 30197484 DOI: 10.3748/wjg.v24.i33.3786] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
190 Fan X, Xie Y, Chen H, Guo X, Ma Y, Pang X, Huang Y, He F, Liu S, Yu Y, Hong M, Xiao J, Wan X, Li M, Zheng J. Distant Metastasis Risk Definition by Tumor Biomarkers Integrated Nomogram Approach for Locally Advanced Nasopharyngeal Carcinoma. Cancer Control 2019;26:1073274819883895. [PMID: 31642331 DOI: 10.1177/1073274819883895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
191 Huang W, Zhou K, Jiang Y, Chen C, Yuan Q, Han Z, Xie J, Yu S, Sun Z, Hu Y, Yu J, Liu H, Xiao R, Xu Y, Zhou Z, Li G. Radiomics Nomogram for Prediction of Peritoneal Metastasis in Patients With Gastric Cancer. Front Oncol 2020;10:1416. [PMID: 32974149 DOI: 10.3389/fonc.2020.01416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
192 Zhang X, Han J, Du L, Li X, Hao J, Wang L, Zheng G, Duan W, Xie Y, Zhao Y, Zhang X, Zou M, Wang C. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma. Thorac Cancer 2020;11:728-37. [PMID: 31994347 DOI: 10.1111/1759-7714.13325] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
193 Veríssimo A, Oliveira AL, Sagot MF, Vinga S. DegreeCox - a network-based regularization method for survival analysis. BMC Bioinformatics 2016;17:449. [PMID: 28105908 DOI: 10.1186/s12859-016-1310-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
194 Okugawa Y, Grady WM, Goel A. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology. 2015;149:1204-1225.e12. [PMID: 26216839 DOI: 10.1053/j.gastro.2015.07.011] [Cited by in Crossref: 317] [Cited by in F6Publishing: 323] [Article Influence: 45.3] [Reference Citation Analysis]
195 Rashid H, Hossain B, Siddiqua T, Kabir M, Noor Z, Ahmed M, Haque R. Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases. Front Mol Biosci 2020;7:181. [PMID: 32850969 DOI: 10.3389/fmolb.2020.00181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
196 Fadaka AO, Ojo BA, Adewale OB, Esho T, Pretorius A. Effect of dietary components on miRNA and colorectal carcinogenesis. Cancer Cell Int 2018;18:130. [PMID: 30202241 DOI: 10.1186/s12935-018-0631-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
197 Tang J, Ma W, Zeng Q, Tan J, Cao K, Luo L. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer. Dis Markers 2019;2019:3815952. [PMID: 31976020 DOI: 10.1155/2019/3815952] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
198 Rinnerthaler G, Gampenrieder SP, Hackl H, Steiner M, Monzo-Fuentes C, Melchardt T, Magnes T, Huemer F, Westphal T, Hufnagl C, Hauser-Kronberger C, Egle A, Greil R. Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial. J Clin Med 2020;9:E1663. [PMID: 32492882 DOI: 10.3390/jcm9061663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
199 Duan S, Wang P, Liu F, Huang H, An W, Pan S, Wang X. Novel immune-risk score of gastric cancer: A molecular prediction model combining the value of immune-risk status and chemosensitivity. Cancer Med 2019;8:2675-85. [PMID: 30945466 DOI: 10.1002/cam4.2077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
200 Chen R, Zhang C, Cheng Y, Wang S, Lin H, Zhang H. LncRNA UCC promotes epithelial-mesenchymal transition via the miR-143-3p/SOX5 axis in non-small-cell lung cancer. Lab Invest 2021;101:1153-65. [PMID: 33824420 DOI: 10.1038/s41374-021-00586-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
201 Huang Y, Chen CL, Yuan JJ, Li HM, Han XR, Chen RC, Guan WJ, Zhong NS. Sputum Exosomal microRNAs Profiling Reveals Critical Pathways Modulated By Pseudomonas aeruginosa Colonization In Bronchiectasis. Int J Chron Obstruct Pulmon Dis 2019;14:2563-73. [PMID: 31819394 DOI: 10.2147/COPD.S219821] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
202 Niu XK, He XF. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma. World J Gastroenterol 2021; 27(2): 189-207 [PMID: 33510559 DOI: 10.3748/wjg.v27.i2.189] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
203 Ma Q, Geng K, Xiao P, Zeng L. Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer. Biomed Res Int 2021;2021:5963868. [PMID: 34518802 DOI: 10.1155/2021/5963868] [Reference Citation Analysis]
204 Mo S, Ma X, Li Y, Zhang L, Hou T, Han-Zhang H, Qian J, Cai S, Huang D, Peng J. Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer. J Immunother Cancer 2020;8:e000881. [PMID: 32859741 DOI: 10.1136/jitc-2020-000881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
205 Zhang C, Liu H, Xu P, Tan Y, Xu Y, Wang L, Liu B, Chen Q, Tian D. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis. BMC Cancer 2021;21:251. [PMID: 33750353 DOI: 10.1186/s12885-021-07972-9] [Reference Citation Analysis]
206 Jacob H, Stanisavljevic L, Storli KE, Hestetun KE, Dahl O, Myklebust MP. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. Oncotarget 2017;8:87837-47. [PMID: 29152124 DOI: 10.18632/oncotarget.21237] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
207 Jie M, Feng T, Huang W, Zhang M, Feng Y, Jiang H, Wen Z. Subcellular Localization of miRNAs and Implications in Cellular Homeostasis. Genes (Basel) 2021;12:856. [PMID: 34199614 DOI: 10.3390/genes12060856] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Xiong Y, Deng Y, Wang K, Zhou H, Zheng X, Si L, Fu Z. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data. EBioMedicine 2018;36:183-95. [PMID: 30243491 DOI: 10.1016/j.ebiom.2018.09.021] [Cited by in Crossref: 46] [Cited by in F6Publishing: 56] [Article Influence: 11.5] [Reference Citation Analysis]
209 Peng Q, Zhang X, Min M, Zou L, Shen P, Zhu Y. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis. Oncotarget. 2017;8:44893-44909. [PMID: 28415652 DOI: 10.18632/oncotarget.16488] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
210 Kandimalla R, Gao F, Matsuyama T, Ishikawa T, Uetake H, Takahashi N, Yamada Y, Becerra C, Kopetz S, Wang X, Goel A. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer. Clin Cancer Res. 2018;24:3867-3877. [PMID: 29514841 DOI: 10.1158/1078-0432.ccr-17-3236] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
211 Stiegelbauer V, Perakis S, Deutsch A, Ling H, Gerger A, Pichler M. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer. World J Gastroenterol 2014; 20(33): 11727-11735 [PMID: 25206276 DOI: 10.3748/wjg.v20.i33.11727] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
212 Li J, Zhang J, Hu H, Cai Y, Ling J, Wu Z, Deng Y. Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients. Cancer Manag Res 2020;12:3301-10. [PMID: 32494194 DOI: 10.2147/CMAR.S243490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
213 Wei R, Wang J, Wang X, Xie G, Wang Y, Zhang H, Peng CY, Rajani C, Kwee S, Liu P, Jia W. Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning. EBioMedicine 2018;35:124-32. [PMID: 30100397 DOI: 10.1016/j.ebiom.2018.07.041] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
214 Lee KS, Nam SK, Koh J, Kim DW, Kang SB, Choe G, Kim WH, Lee HS. Stromal Expression of MicroRNA-21 in Advanced Colorectal Cancer Patients with Distant Metastases. J Pathol Transl Med 2016;50:270-7. [PMID: 27240857 DOI: 10.4132/jptm.2016.03.19] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
215 Zhou L, Jiang Y, Liu X, Li L, Yang X, Dong C, Liu X, Lin Y, Li Y, Yu J, He R, Huang S, Liu G, Zhang Y, Jeong LS, Hoffman RM, Jia L. Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-κB-CCL2 signaling in lung cancer. Oncogene 2019;38:5792-804. [PMID: 31243299 DOI: 10.1038/s41388-019-0840-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
216 Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, Silliman N, Tacey M, Wong HL, Christie M, Kosmider S, Skinner I, Wong R, Steel M, Tran B, Desai J, Jones I, Haydon A, Hayes T, Price TJ, Strausberg RL, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016;8:346ra92. [PMID: 27384348 DOI: 10.1126/scitranslmed.aaf6219] [Cited by in Crossref: 543] [Cited by in F6Publishing: 518] [Article Influence: 108.6] [Reference Citation Analysis]
217 Yang C, Dou R, Wei C, Liu K, Shi D, Zhang C, Liu Q, Wang S, Xiong B. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis. Mol Ther 2021;29:2088-107. [PMID: 33571679 DOI: 10.1016/j.ymthe.2021.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
218 Kuang XY, Chen L, Zhang ZJ, Liu YR, Zheng YZ, Ling H, Qiao F, Li S, Hu X, Shao ZM. Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients. Oncotarget 2015;6:22227-38. [PMID: 26087399 DOI: 10.18632/oncotarget.4276] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
219 Li C, Dong Q, Che X, Xu L, Li Z, Fan Y, Hou K, Wang S, Qu J, Xu L, Wen T, Yang X, Qu X, Liu Y. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma. BMC Cancer 2018;18:681. [PMID: 29940895 DOI: 10.1186/s12885-018-4526-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
220 Jiang Y, Chen C, Xie J, Wang W, Zha X, Lv W, Chen H, Hu Y, Li T, Yu J, Zhou Z, Xu Y, Li G. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. EBioMedicine. 2018;36:171-182. [PMID: 30224313 DOI: 10.1016/j.ebiom.2018.09.007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 13.8] [Reference Citation Analysis]
221 Chen Y, Ma C, Zhang W, Chen Z, Ma L. Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer. Diagn Pathol 2014;9:88. [PMID: 24774218 DOI: 10.1186/1746-1596-9-88] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
222 Wang Z, Zhou Q, Zeng H, Zhang H, Liu Z, Huang Q, Xiong Y, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Zhu Y, Xu L, Dai B, Liu L, Guo J, Xu J. Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer. Oncoimmunology 2020;9:1747332. [PMID: 32313725 DOI: 10.1080/2162402X.2020.1747332] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
223 Pak K, Kim YH, Suh S, Goh TS, Jeong DC, Kim SJ, Kim IJ, Han ME, Oh SO. Development of a risk scoring system for patients with papillary thyroid cancer. J Cell Mol Med 2019;23:3010-5. [PMID: 30729678 DOI: 10.1111/jcmm.14208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
224 She Y, Zhang L, Zhu H, Dai C, Xie D, Xie H, Zhang W, Zhao L, Zou L, Fei K, Sun X, Chen C. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules. Eur Radiol 2018;28:5121-8. [PMID: 29869172 DOI: 10.1007/s00330-018-5509-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
225 Wang Y, Chen L, Ju L, Qian K, Wang X, Xiao Y, Wang G. Epigenetic signature predicts overall survival clear cell renal cell carcinoma. Cancer Cell Int 2020;20:564. [PMID: 33292239 DOI: 10.1186/s12935-020-01640-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
226 Lin N, Liu Q, Wang M, Wang Q, Zeng K. Usefulness of miRNA-338-3p in the diagnosis of pemphigus and its correlation with disease severity. PeerJ 2018;6:e5388. [PMID: 30083474 DOI: 10.7717/peerj.5388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
227 Yao Y, Hu J, Shen Z, Yao R, Liu S, Li Y, Cong H, Wang X, Qiu W, Yue L. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1. J Cell Mol Med 2015;19:760-9. [PMID: 25639535 DOI: 10.1111/jcmm.12432] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
228 Bowen CM, Walter L, Borras E, Wu W, Ozcan Z, Chang K, Bommi PV, Taggart MW, Thirumurthi S, Lynch PM, Reyes-Uribe L, Scheet PA, Sinha KM, Vilar E. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Cancer Prev Res (Phila) 2021;14:851-62. [PMID: 34266857 DOI: 10.1158/1940-6207.CAPR-20-0496] [Reference Citation Analysis]
229 Sehgal V, Seviour EG, Moss TJ, Mills GB, Azencott R, Ram PT. Robust Selection Algorithm (RSA) for Multi-Omic Biomarker Discovery; Integration with Functional Network Analysis to Identify miRNA Regulated Pathways in Multiple Cancers. PLoS One 2015;10:e0140072. [PMID: 26505200 DOI: 10.1371/journal.pone.0140072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
230 Guo Y, Bao Y, Yang W. Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis. Int J Mol Sci 2017;18:E890. [PMID: 28441730 DOI: 10.3390/ijms18040890] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
231 Chen X, Shi K, Wang Y, Song M, Zhou W, Tu H, Lin Z. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation. Oncotarget 2015;6:37544-56. [PMID: 26462034 DOI: 10.18632/oncotarget.6065] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
232 Yang Y, Qu A, Wu Q, Zhang X, Wang L, Li C, Dong Z, Du L, Wang C. Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer. Aging (Albany NY) 2020;12:35-52. [PMID: 31926112 DOI: 10.18632/aging.102228] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
233 Kawai K, Sunami E, Yamaguchi H, Ishihara S, Kazama S, Nozawa H, Hata K, Kiyomatsu T, Tanaka J, Tanaka T, Nishikawa T, Kitayama J, Watanabe T. Nomograms for colorectal cancer: A systematic review. World J Gastroenterol 2015; 21(41): 11877-11886 [PMID: 26557011 DOI: 10.3748/wjg.v21.i41.11877] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
234 Wang W, Xu C, Ren Y, Wang S, Liao C, Fu X, Hu H. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma. Stem Cells Int 2021;2021:7036059. [PMID: 34691191 DOI: 10.1155/2021/7036059] [Reference Citation Analysis]
235 Weng W, Feng J, Qin H, Ma Y, Goel A. An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach. Future Oncol 2015;11:1791-808. [PMID: 26075447 DOI: 10.2217/fon.15.83] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
236 Barbier J, Chen X, Sanchez G, Cai M, Helsmoortel M, Higuchi T, Giraud P, Contreras X, Yuan G, Feng Z, Nait-Saidi R, Deas O, Bluy L, Judde JG, Rouquier S, Ritchie W, Sakamoto S, Xie D, Kiernan R. An NF90/NF110-mediated feedback amplification loop regulates dicer expression and controls ovarian carcinoma progression. Cell Res 2018;28:556-71. [PMID: 29563539 DOI: 10.1038/s41422-018-0016-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
237 Yu X, Yang Q, Wang D, Li Z, Chen N, Kong DX. Predicting lung adenocarcinoma disease progression using methylation-correlated blocks and ensemble machine learning classifiers. PeerJ 2021;9:e10884. [PMID: 33628643 DOI: 10.7717/peerj.10884] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Mo S, Zhou Z, Li Y, Hu X, Ma X, Zhang L, Cai S, Peng J. Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer. Cancer Cell Int 2020;20:285. [PMID: 32655317 DOI: 10.1186/s12935-020-01382-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
239 Taieb J, Gallois C. Adjuvant Chemotherapy for Stage III Colon Cancer. Cancers (Basel) 2020;12:E2679. [PMID: 32961795 DOI: 10.3390/cancers12092679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
240 Xue B, Jiang J, Chen L, Wu S, Zheng X, Zheng X, Tang K. Development and Validation of a Radiomics Model Based on 18F-FDG PET of Primary Gastric Cancer for Predicting Peritoneal Metastasis. Front Oncol 2021;11:740111. [PMID: 34765549 DOI: 10.3389/fonc.2021.740111] [Reference Citation Analysis]
241 He Y, Qin Y, Wang S, Wang X, Wang C. Electricity consumption probability density forecasting method based on LASSO-Quantile Regression Neural Network. Applied Energy 2019;233-234:565-75. [DOI: 10.1016/j.apenergy.2018.10.061] [Cited by in Crossref: 56] [Article Influence: 18.7] [Reference Citation Analysis]
242 Zhang ZY, Luo QF, Yin XW, Dai ZL, Basnet S, Ge HY. Nomograms to predict survival after colorectal cancer resection without preoperative therapy. BMC Cancer 2016;16:658. [PMID: 27553083 DOI: 10.1186/s12885-016-2684-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
243 Xu L, Li M, Wang M, Yan D, Feng G, An G. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer. BMC Cancer 2014;14:714. [PMID: 25255814 DOI: 10.1186/1471-2407-14-714] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
244 Du T, Han J. Arginine Metabolism and Its Potential in Treatment of Colorectal Cancer. Front Cell Dev Biol 2021;9:658861. [PMID: 34095122 DOI: 10.3389/fcell.2021.658861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
245 Zhang Y, Li M, Ding Y, Fan Z, Zhang J, Zhang H, Jiang B, Zhu Y. Serum MicroRNA profile in patients with colon adenomas or cancer. BMC Med Genomics 2017;10:23. [PMID: 28427387 DOI: 10.1186/s12920-017-0260-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
246 Vychytilova-Faltejskova P, Merhautova J, Machackova T, Gutierrez-Garcia I, Garcia-Solano J, Radova L, Brchnelova D, Slaba K, Svoboda M, Halamkova J, Demlova R, Kiss I, Vyzula R, Conesa-Zamora P, Slaby O. MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9. Oncogenesis 2017;6:399. [PMID: 29199273 DOI: 10.1038/s41389-017-0006-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
247 Tamburrino D, Guarneri G, Pagnanelli M, Crippa S, Partelli S, Belfiori G, Capurso G, Falconi M. Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence? Ann Surg Oncol 2021;28:2312-22. [PMID: 32920722 DOI: 10.1245/s10434-020-09097-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
248 Liu Y, Wu L, Ao H, Zhao M, Leng X, Liu M, Ma J, Zhu J. Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer. Aging (Albany NY). 2019;11:11440-11462. [PMID: 31811814 DOI: 10.18632/aging.102544] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 13.7] [Reference Citation Analysis]
249 Xu Z, Xu L, Liu L, Li H, Jin J, Peng M, Huang Y, Xiao H, Li Y, Guan H. A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma. Front Oncol 2021;11:625452. [PMID: 33954109 DOI: 10.3389/fonc.2021.625452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
250 Xue W, Li J, Wang F, Han P, Liu Y, Cui B. A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma. Oncotarget 2017;8:101298-308. [PMID: 29254165 DOI: 10.18632/oncotarget.21064] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
251 Murakami Y, Kawahara D, Tani S, Kubo K, Katsuta T, Imano N, Takeuchi Y, Nishibuchi I, Saito A, Nagata Y. Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using 18F-FDG PET Images. Diagnostics (Basel) 2021;11:1049. [PMID: 34200332 DOI: 10.3390/diagnostics11061049] [Reference Citation Analysis]
252 Liu Y, Wu J, Huang W, Weng S, Wang B, Chen Y, Wang H. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer. J Transl Med 2020;18:201. [PMID: 32410620 DOI: 10.1186/s12967-020-02366-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
253 Tian S, Meng G, Zhang W. A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma. Cancer Manag Res 2019;11:131-42. [PMID: 30588115 DOI: 10.2147/CMAR.S185875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
254 Yang B, Zhong J, Zhong J, Ma L, Li A, Ji H, Zhou C, Duan S, Wang Q, Zhu C, Tian J, Zhang L, Wang F, Zhu H, Lu G. Development and Validation of a Radiomics Nomogram Based on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Clinicopathological Factors to Predict the Survival Outcomes of Patients With Non-Small Cell Lung Cancer. Front Oncol 2020;10:1042. [PMID: 32766134 DOI: 10.3389/fonc.2020.01042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]